Skip to content
Bored Studies
Recruiting

MMA Embolization for Refractory Chronic Migraine

Cerenovus, Part of DePuy Synthes Products, Inc. · NCT06735833

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–65 · All sexes
Healthy volunteers
Not accepted (a condition is required)
Study type
Interventional · Not applicable
Target enrollment
70
US sites recruiting
8
Study start
April 23, 2025
Record last updated
September 25, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This is a prospective, multi-center, feasibility study to investigate safety and effectiveness of TRUFILL n-BCA liquid embolic system in bilateral middle meningeal artery (MMA) embolization for the treatment of refractory chronic migraine.

Being studied: Middle Meningeal Artery embolization

Conditions: Migraine Disorders

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Participant Inclusion Criteria, Candidates for this study must meet ALL the following inclusion criteria:

  • Patient is between 18 and 65 years of age (inclusive) at the time of consent
  • Age of onset of Chronic Migraine \<= 64 years
  • Age of onset of migraine diagnosis \< 50 years
  • Patient has a current diagnosis of refractory migraine
  • Patient has a current diagnosis of Chronic migraine

Participant Exclusion Criteria, Candidates will be excluded from participation if ANY of the following apply:

  • Patients with a history for the last 2 years of other primary headache types, or secondary headache types except medication overuse headache
  • Patients with diagnosis of hemiplegic migraine or migrainous infarct
  • Patients with current regular use of Opioids, Cannabis, Medical Marijuana, etc
  • Women who are pregnant, lactating, or who are of childbearing age
  • Current involvement in an investigational (drug, device, etc.) clinical trial that may confound study endpoints. Participants in observational, natural history, and/or epidemiological studies not involving intervention are eligible. Sponsor approval is required

Recruiting US locations

Study contacts (from the official record)

  • Study Contact · RA-MIGRAINECNV202302@ITS.JNJ.com
All neurology studies in California →
MMA Embolization for Refractory Chronic Migraine (NCT06735833) | Bored Studies